(Q44084715)

English

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Werle B

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fromantin C

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Alexandre A

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kohli E

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pothier P

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

23-24

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2983-2990

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12 in infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to baculovirus expressed protein fragment amino acids 190-289 of respiratory syncytial virus (RSV) fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal cytokine production in viral acute upper respiratory infection of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo induction of type 1 and 2 immune responses against protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900172-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(99)00172-3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44084715&oldid=2106424859"